← Back to Search

Miraculin for Taste Dysfunction in Head and Neck Cancer Patients

Phase 3
Recruiting
Led By Sue Yom, MD, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Eastern Cooperative Oncology Group (ECOG) performance status <= 2 (Karnofsky >= 60%)
Age >=18 years at screening visit
Must not have
Inability to complete patient-reported outcomes (PROs) and quality of life questionnaires in English
Patient-reported pre-existing dysgeusia prior to beginning radiation therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Pivotal Trial

Summary

This trial tests if miracle fruit cubes can help head and neck cancer patients undergoing radiation therapy by improving their sense of taste, making it easier for them to eat and maintain nutrition.

Who is the study for?
This trial is for adults over 18 with head and neck cancer, who can sign consent forms and have a performance status indicating they're mostly self-sufficient. They must be scheduled for radiation therapy, possibly with chemo, after surgery but cannot join if they had taste issues before treatment or rely on tube feeding.
What is being tested?
The study tests whether miraculin from miracle fruit can help patients undergoing radiation therapy maintain their sense of taste. Participants will receive either the miraculin cube or a placebo to see which one better prevents taste dysfunction during the first half of their treatment.
What are the potential side effects?
Since this trial involves a natural substance found in miracle fruit, side effects are expected to be minimal. However, participants may potentially experience allergic reactions due to sensitivity to berries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can take care of myself but might not be able to do heavy physical work.
Select...
I am 18 years old or older.
Select...
I have a confirmed diagnosis of head and neck cancer and have undergone surgery including neck dissection.
Select...
My treatment plan aims to cure my cancer and may include radiation therapy with or without chemotherapy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot complete questionnaires in English.
Select...
I had changes in taste before starting radiation therapy.
Select...
I am getting my nutrition through a tube or IV before starting radiation therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Taste Assessment scores over time
Secondary study objectives
Change in Chemotherapy-induced taste alteration scale (CiTAS) scores over time
Change in Diet Diversity Scores over time
Change in EuroQol five-dimensional Questionnaire (EQ-5D) scores over time
+8 more

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Miracle FruitExperimental Treatment1 Intervention
Participants will receive 1 Miracle Fruit Farm miracle fruit cube by mouth three times a day before meals
Group II: Miracle Fruit PlaceboPlacebo Group1 Intervention
Participants will receive 1 placebo cube by mouth three times a day before meals

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for taste dysfunction include the use of miracle fruit cubes, which alter taste perception by temporarily modifying taste receptors. This is achieved through miraculin, a glycoprotein that binds to taste buds and changes the way they perceive sour flavors, making them taste sweet. This mechanism is particularly important for patients undergoing treatments like radiation therapy for head and neck cancer, as it can help improve their taste function and overall quality of life during a period when taste alterations are common and difficult to manage.
Self-perceived Taste and Flavor Perception: Associations With Quality of Life in Patients With Olfactory Loss.

Find a Location

Who is running the clinical trial?

Miracle Fruit FarmUNKNOWN
University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,887,910 Total Patients Enrolled
Mount Zion Health FundOTHER
12 Previous Clinical Trials
887 Total Patients Enrolled
Sue Yom, MD, PhDPrincipal InvestigatorUniversity of California, San Francisco
3 Previous Clinical Trials
642 Total Patients Enrolled

Media Library

Miraculin Clinical Trial Eligibility Overview. Trial Name: NCT05273307 — Phase 3
Taste Dysfunction Research Study Groups: Miracle Fruit Placebo, Miracle Fruit
Taste Dysfunction Clinical Trial 2023: Miraculin Highlights & Side Effects. Trial Name: NCT05273307 — Phase 3
Miraculin 2023 Treatment Timeline for Medical Study. Trial Name: NCT05273307 — Phase 3
~13 spots leftby Apr 2026